According to a new report from Intel Market Research, the global Darunavir market was valued at USD 1.42 billion in 2025 and is projected to grow from USD 1.51 billion in 2026 to USD 2.18 billion by 2034, exhibiting a robust CAGR of 4.7% during the forecast period. Darunavir (DRV), sold under the brand name Prezista among others, is an antiretroviral medication primarily used to treat and...
English
Indonesia
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek